You are seeing Ask web results for poor antigen because there was not a match on Dictionary.com.
|
Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis. 2009 Oct; [Epub ahead of print]; Poor Clinical Sensitivity of Rapid Antigen Test for Influenza A Pandemic (H1N1) 2009 Virus;
|
|
Poor Clinical Sensitivity of Rapid Antigen Test for Influenza A Pandemic (H1N1) 2009 Virus ... Antigen-based rapid assays can be used as bedside tests and have been successfully applied in studies of influenza caused by the seasonal strains A (H1N1) and A (H3N2) (4).
|
|
A majority of HBsAg vaccine recipients show good anti-HBs antibody responses but poor antigen specific lymphoproliferative responses. ... We investigated the basis for this poor in vitro antigen specific proliferative responsiveness in vaccinees who had received the standard three dose schedule (0, 1 and 6 months) of...
|
|
It is concluded that conventional CD4+ T cells against the polypeptide backbone of aPPG are not induced because the molecule resists antigen processing due to its extensive and complex carbohydrate modification.
|
|
Likewise, in immunized animals, the purified native compound was a very poor B-cell antigen and was not CD4+ T-cell immunogenic, in contrast to the Escherichia coli-expressed recombinant form.
|
|
In the poor antigen-producing T H E L cells there was a significantly greater accumulation of such virus than in VERO cells (Fig, 2). Pre-treatment of the virus with trypsin reduced the level reached in T H E L cells bringing it near to that seen in VERO cells.
|
|
Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. ... Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus...Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus.
|
|
The amount of prostate-specific antigen (PSA) in a man's bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer, according to a study in the April 4 Journal of the National Cancer Institute.
|
|
However, the delivery of DNA and mRNA had significantly different outcomes in transfected DC. DC nucleofected with DNA encoding green fluorescent protein (GFP) had poor antigen expression and viability and were refractory to maturation with CD40 ligand.
|
|
Max Petersson2,*, Jehad Charo*, Flavio Salazar-Onfray*, Gabriele Noffz , Mariette Mohaupt , Zhihai Qin , George Klein*, Thomas Blankenstein and Rolf Kiessling*, ... * Microbiology and Tumor Biology Center (MTC), Karolinska Institute, Stockholm, Sweden; Max-Delbruck Center for ... Alert me when this article is cited...
|
